BionicM Establishes U.S. Headquarters to Serve American Market

Tokyo-based BionicM has launched its U.S. subsidiary—BionicM USA—in Ashburn, Va., near the nation’s capital. The move reflects the company’s strategy to leverage significant growth opportunities within the world’s largest prosthetics market.

The new U.S. office will serve as the operational hub, enhancing inventory capabilities to reduce delivery lead times and accelerate sales efforts. It will also ensure comprehensive after-sales service for prosthetics practitioners and patients using the firm’s advanced powered microprocessor knee solutions.

BionicM USA claims it is well-positioned to meet increasing demand for powered prosthetic solutions. Notable achievements leading up to the U.S. headquarters launch include the first delivery of the Bio Leg to U.S. customers and securing $3 million in fundraising, both of which occurred last September.

Bio Leg Showcased at CES 2025

BionicM’s flagship product, the Bio Leg, has been named a CES 2025 Best of Innovation winner. Following successful PDAC insurance coverage approval in May 2024, the company introduced Bio Leg to the U.S. market last summer.

The Bio Leg powered microprocessor knee revolutionizes mobility by replacing lost muscle strength with advanced robotics technology. This solution reduces physical strain and promotes natural, intuitive movement, empowering users to engage in active lifestyles and significantly enhancing their overall quality of life.

After extensive trials involving more than 300 participants, the Bio Leg received U.S. Food and Drug Administration Class II medical device registration in July 2023 and U.S. medical insurance coverage approval in May 2024. Users have praised its seamless integration with their movements, highlighting its combination of safety, ease of use, and life-changing capabilities.

BionicM is showcasing the Bio Leg at this year’s Consumer Electronics Show (CES) in Las Vegas (through Jan. 11). Visitors can learn more about the leg at the J-Startup/JAPAN Pavilion in Eureka Park (Booth No. 61000 & 61001, Tech West, Venetian Expo, Level 1, Hall G).

Founded in 2018 as a spin-off from the University of Tokyo, BionicM emerged from the R&D spearheaded by CEO Sunny Xiaojun Sun during his doctoral studies at the University of Tokyo, under the mentorship of Professor Inaba (currently Professor Emeritus). Supported by JST’s START program, BionicM leverages advanced humanoid robotics technology to develop and market powered microprocessor knees.

As a global startup, BionicM is driven by its mission to enhance mobility and improve the quality of life (QOL) for individuals with lower-limb amputations.